Harmful impact of EU clinical trials directive: trial of alerting drug in fibromyalgia has had to be abandoned.

BMJ. 2006 Mar 18;332(7542):666. doi: 10.1136/bmj.332.7542.666.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Clinical Trials as Topic / legislation & jurisprudence*
  • European Union
  • Fibromyalgia / drug therapy*
  • Guidelines as Topic
  • Humans